Albany International Reports Third-Quarter Results
Third-quarter Financial Highlights
-
Net sales were
$191.3 million , an increase of 7.0% compared to Q3 2015. Net sales increased 11.4% as the result of the Q2 2016 acquisition of Harris Corporation’s composite aerostructures division (see Tables 1 and 2). -
Q3 2016 net income attributable to the Company was
$13.1 million ($0.41 per share), compared to$9.7 million ($0.30 per share) in Q3 2015. Net income attributable to the Company, excluding adjustments (a non-GAAP measure), was$0.41 per share, compared to$0.47 in Q3 2015 (see Table 16). -
Adjusted EBITDA (a non-GAAP measure) was
$42.7 million , compared to$42.0 million in Q3 2015 (see Tables 7 and 8).
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161031006132/en/
Q3 2016 income before income taxes was
As previously reported, in the second quarter of 2016, the Company completed the acquisition of Harris Corporation’s composite aerostructures division. Table 1 summarizes key financial metrics of the acquired business, which is included in the AEC segment.
Table 1 |
||||
(in thousands, excluding percentages) |
Three Months |
|||
Net sales | $20,354 | |||
Gross profit | 1,697 | |||
Gross profit percentage | 8.3% | |||
Selling, technical, general and research expenses | $3,157 | |||
Operating income/(loss) | (1,460) | |||
Depreciation and amortization (D&A) | 4,480 | |||
EBITDA [Operating income/(loss) + D&A] | 3,020 | |||
Adjusted EBITDA [Operating income/(loss) + D&A] | 3,020 | |||
Table 2 summarizes net sales and the effect of changes in currency translation rates:
Table 2 |
||||||||||||||||||||||||
|
Net Sales Three Months ended September 30, |
Percent |
Impact of |
Percent Change |
||||||||||||||||||||
(in thousands, excluding percentages) |
2016 |
2015 |
||||||||||||||||||||||
Machine Clothing (MC) | $ | 143,248 | $ | 154,522 | -7.3 | % | $ | 212 | -7.4 | % | ||||||||||||||
Albany Engineered Composites (AEC) | 48,024 | 24,267 | 97.9 | % | 29 | 97.8 | % | |||||||||||||||||
Total | $ | 191,272 | $ | 178,789 | 7.0 | % | $ | 241 | 6.8 | % |
Against a strong Q3 2015, MC net sales decreased in virtually every
region and grade. The decrease reflects a return to a more normal
seasonal pattern in Q3 2016, combined with weakness in the publication
grades in
Gross profit declined from
Q3 2016 selling, technical, general, and research (STG&R) expenses were
The following table presents third-quarter expenses associated with internally funded research and development by segment:
Table 3 |
|||||||||||
|
Research and development |
||||||||||
(in thousands) |
2016 |
2015 |
|||||||||
Machine Clothing | $ | 3,937 | $ | 4,775 | |||||||
Albany Engineered Composites | 2,656 | 2,769 | |||||||||
Corporate expenses | - | 190 | |||||||||
Total | $ | 6,593 | $ | 7,734 | |||||||
The following table summarizes third-quarter operating income by segment:
Table 4 |
|||||||||||||
|
Operating Income/(loss) |
||||||||||||
(in thousands) |
2016 |
2015 |
|||||||||||
Machine Clothing | $ | 40,039 | $ | 41,956 | |||||||||
Albany Engineered Composites | (4,529 | ) | (4,191 | ) | |||||||||
Corporate expenses |
(10,690 |
) | (11,922 | ) | |||||||||
Total | $ | 24,820 | $ | 25,843 | |||||||||
Segment operating income was affected by restructuring and currency
revaluation, as shown in Table 5 below. AEC restructuring charges
include costs associated with the consolidation of the Company’s legacy
programs into its
Table 5 |
||||||||||||||||||||||
(in thousands) |
Expenses/(gain) in Q3 2016 |
Expenses/(gain) in Q3 2015 |
||||||||||||||||||||
Machine Clothing | ($212 | ) | $ | 86 | $ | 3,717 | ($2,005 | ) | ||||||||||||||
Albany Engineered Composites | 640 | - | - | - | ||||||||||||||||||
Corporate expenses | (102 | ) | 4 | - | 4 | |||||||||||||||||
Total | $ | 326 | $ | 90 | $ | 3,717 | ($2,001 | ) | ||||||||||||||
Q3 2016 Other income/expense, net, was expense of
The following table summarizes currency revaluation effects on certain financial metrics:
Table 6 |
|||||||||||||
|
Income/(loss) attributable |
||||||||||||
(in thousands) |
2016 |
2015 |
|||||||||||
Operating income | ($90 | ) | $ | 2,001 | |||||||||
Other income/(expense), net | 312 | (953 | ) | ||||||||||
Total | $ | 222 | $ | 1,048 | |||||||||
The Company’s income tax rate based on income from continuing operations
was 37.5% for Q3 2016, compared to 38.0% for the same period of 2015.
Discrete tax charges and the effect of a change in the estimated tax
rate decreased income tax expense by
The following tables provide a reconciliation of net income to EBITDA and Adjusted EBITDA:
Table 7 |
|||||||||||||||||||||||||||
Three Months ended September 30, 2016
(in thousands) |
Machine |
Albany |
Corporate |
Total |
|||||||||||||||||||||||
Net income (GAAP) | $ | 40,039 | ($4,529 | ) | ($22,101 | ) | $ | 13,409 | |||||||||||||||||||
Interest expense, net | - | - | 3,681 | 3,681 | |||||||||||||||||||||||
Income tax expense | - | - | 7,488 | 7,488 | |||||||||||||||||||||||
Depreciation and amortization | 9,032 | 8,027 | 1,386 | 18,445 | |||||||||||||||||||||||
EBITDA (non-GAAP) | 49,071 | 3,498 | (9,546 | ) | 43,023 | ||||||||||||||||||||||
Restructuring expenses, net | (212 | ) | 640 | (102 | ) | 326 | |||||||||||||||||||||
Foreign currency revaluation (gains)/losses | 86 | - | (308 | ) | (222 | ) | |||||||||||||||||||||
Pretax (income) attributable to non-controlling interest in ASC | - | (428 | ) | - | (428 | ) | |||||||||||||||||||||
Adjusted EBITDA (non-GAAP) | $ | 48,945 | $ | 3,710 | ($9,956 | ) | $ | 42,699 | |||||||||||||||||||
|
||||||||||||||||||||||||||
Table 8 |
||||||||||||||||||||||||||
Three Months ended September 30, 2015
(in thousands) |
Machine |
Albany |
Corporate |
Total |
||||||||||||||||||||||
Net income (GAAP) | $ | 41,956 | ($4,191 | ) | ($28,085 | ) | $ | 9,680 | ||||||||||||||||||
Interest expense, net | - | - | 2,671 | 2,671 | ||||||||||||||||||||||
Income tax expense | - | - | 12,243 | 12,243 | ||||||||||||||||||||||
Depreciation and amortization | 9,660 | 2,981 | 2,102 | 14,743 | ||||||||||||||||||||||
EBITDA (non-GAAP) | 51,616 | (1,210 | ) | (11,069 | ) | 39,337 | ||||||||||||||||||||
Restructuring expenses, net | 3,717 | - | - | 3,717 | ||||||||||||||||||||||
Foreign currency revaluation (gains)/losses | (2,005 | ) | - | 957 | (1,048 | ) | ||||||||||||||||||||
Pretax income attributable to non-controlling interest in ASC | - | (25 | ) | - | (25 | ) | ||||||||||||||||||||
Adjusted EBITDA (non-GAAP) | $ | 53,328 | ($1,235 | ) | ($10,112 | ) | $ | 41,981 | ||||||||||||||||||
Capital spending was
CFO Comments
CFO and Treasurer
“Capital expenditures in Q3 were
CEO Comments
President and CEO
“Against a very strong Q3 2015, MC sales declined 7%. Unlike a year ago,
in Q3 this year we experienced a normal seasonal pattern of weakness in
the two summer months of the quarter, followed by a strong finish.
Compared to Q3 2015, sales were down in virtually every region and
grade. However, except for declines in publication grades in
“New product performance in Q3 across all of our product lines was
especially strong, with the new technology platform having a significant
impact on our competitive position on new machines in the tissue and
nonwoven grades. In the
“MC profitability followed the same pattern as sales. Compared to the strong Q3 2015, gross margin dropped from 48.4% to 47.5%, segment net income dropped by 5% and Adjusted EBITDA by 8%. But, in absolute terms and on a sequential basis, gross margins, net income, and Adjusted EBITDA remained strong and at roughly the same levels as the previous three quarters, for all the same reasons -- continuous productivity improvements, good plant utilization, low material costs, and the cumulative effect of the restructuring efforts of the previous quarters.
“AEC also performed well. Including our new division, sales were
“There were a number of significant developments in the quarter. The
ramp up of LEAP fan blades and cases, which accounted for 35% of Q3
sales, is proceeding well, with excellent progress on yield, cost, and
capacity. Preparations for Plant 3 in Querétaro,
“As for our new division, the three key long-term growth programs (JSF
airframe parts, 787 fuselage frames, and CH-53K parts) and the largest
legacy program (
“Finally, our new business development efforts continue along three
fronts – competing for incremental new business on existing aerospace
platforms (commercial and defense, engines and airframes), collaborative
R&D to position AEC to compete on future new aerospace platforms, and
R&D probes into markets outside of aerospace. Of particular note in Q3
was an example of progress on the first of these fronts. AEC was awarded
a contract to produce composite components on an existing platform
utilizing conventional 2D laminate composite technology. We expect this
contract will generate sales of
“Our outlook for both businesses remains unchanged. For MC, given
current market trends and our solid Q3 performance, we continue to
expect full-year Adjusted EBITDA to be at the upper-end of our
previously discussed range of
“As for AEC, we expect a strong end to the year, driven by sequential
growth in LEAP coupled with steady sequential sales in the rest of the
segment. There is some uncertainty associated with end-of-year inventory
effects; Q4 sales might not be as strong as we expect if our customers,
particularly
“In sum, this was another good quarter for Albany, with both businesses remaining firmly on track toward their full-year 2016 and longer-term strategic and financial performance objectives.”
The Company plans a webcast to discuss third-quarter financial results
on
About
This release contains certain non-GAAP metrics, including: percent change in net sales excluding currency rate effects (for each segment and the Company as a whole); EBITDA and Adjusted EBITDA (for each segment and the Company as a whole); net debt; and net income per share attributable to the Company, excluding adjustments. Such items are provided because management believes that, when reconciled from the GAAP items to which they relate, they provide additional useful information to investors regarding the Company’s operational performance.
Presenting increases or decreases in sales, after currency effects are excluded, can give management and investors insight into underlying sales trends. EBITDA, or net income with interest, taxes, depreciation, and amortization added back, is a common indicator of financial performance used, among other things, to analyze and compare core profitability between companies and industries because it eliminates effects due to differences in financing, asset bases and taxes. An understanding of the impact in a particular quarter of specific restructuring costs, acquisition expenses, currency revaluation, or other gains and losses, on net income (absolute as well as on a per-share basis), operating income or EBITDA can give management and investors additional insight into core financial performance, especially when compared to quarters in which such items had a greater or lesser effect, or no effect. Restructuring expenses in the MC segment, while frequent in recent years, are reflective of significant reductions in manufacturing capacity and associated headcount in response to shifting markets, and not of the profitability of the business going forward as restructured. Net debt is, in the opinion of the Company, helpful to investors wishing to understand what the Company’s debt position would be if all available cash were applied to pay down indebtedness. EBITDA, Adjusted EBITDA and net income per share, excluding adjustments, are performance measures that relate to the Company’s continuing operations.
Percent changes in net sales, excluding currency rate effects, is
calculated by converting amounts reported in local currencies into U.S.
dollars at the exchange rate of a prior period. That amount is then
compared to the U.S. dollar amount reported in the current period. The
Company calculates EBITDA by removing the following from Net income:
Interest expense net, Income tax expense, Depreciation and amortization.
Adjusted EBITDA is calculated by: adding to EBITDA costs associated with
restructuring and pension settlement charges; adding (or subtracting)
revaluation losses (or gains); subtracting (or adding) gains (or losses)
from the sale of buildings or investments; subtracting insurance
recovery gains; subtracting (or adding) Income (or loss) attributable to
the non-controlling interest in Albany Safran Composites (ASC); and
adding expenses related to the Company’s acquisition of
EBITDA, Adjusted EBITDA, and net income per share, excluding adjustments, as defined by the Company, may not be similar to EBITDA measures of other companies. Such measures are not considered measurements under GAAP, and should be considered in addition to, but not as substitutes for, the information contained in the Company’s statements of income.
The Company discloses certain income and expense items on a per-share basis. The Company believes that such disclosures provide important insight into underlying quarterly earnings and are financial performance metrics commonly used by investors. The Company calculates the quarterly per-share amount for items included in continuing operations by using the income tax rate based on income from continuing operations and the weighted-average number of shares outstanding for each period. Year-to-date earnings per-share effects are determined by adding the amounts calculated at each reporting period.
Table 9 |
|||||||
Key financial metrics of the acquired business
|
For the period |
||||||
Net sales | $ | 45,990 | |||||
Gross profit | 6,670 | ||||||
Gross profit percentage | 14.5 | % | |||||
Selling, technical, general and research expenses | $ | 6,421 | |||||
Operating income | 249 | ||||||
Depreciation and amortization (D&A) | 7,383 | ||||||
EBITDA [Operating income/(loss) + D&A] | 7,632 | ||||||
Adjusted EBITDA [Operating income/(loss) + D&A] | 7,632 | ||||||
Table 10 |
||||||||||||||||||||||||||||||
(in thousands, except percentages) |
Net Sales |
Percent |
Impact of
|
Percent Change |
||||||||||||||||||||||||||
2016 |
2015 |
|||||||||||||||||||||||||||||
Machine Clothing | $ | 437,445 | $ | 463,577 | -5.6 | % | ($1,872 | ) | -5.2 | % | ||||||||||||||||||||
Albany Engineered Composites | 129,348 | 68,825 | 87.9 | % | 63 | 87.8 | % | |||||||||||||||||||||||
Total | $ | 566,793 | $ | 532,402 | 6.5 | % | ($1,809 | ) | 6.8 | % | ||||||||||||||||||||
Table 11 |
||||||||||||||||||||||
Nine Months ended September 30, 2016
(in thousands) |
Machine |
Albany |
Corporate |
Total |
||||||||||||||||||
Net income (GAAP) | $ | 112,583 | ($14,083 | ) | ($61,674 | ) | $ | 36,826 | ||||||||||||||
Interest expense, net | - | - | 9,610 | 9,610 | ||||||||||||||||||
Income tax expense | - | - | 20,613 | 20,613 | ||||||||||||||||||
Depreciation and amortization | 27,845 | 17,778 | 5,601 | 51,224 | ||||||||||||||||||
EBITDA (non-GAAP) | 140,428 | 3,695 | (25,850 | ) | 118,273 | |||||||||||||||||
Restructuring expenses, net | 5,921 | 1,787 | (55 | ) | 7,653 | |||||||||||||||||
Foreign currency revaluation losses/(gains) | 1,646 | 5 | (2,355 | ) | (704 | ) | ||||||||||||||||
Acquisition expenses | - | 5,367 | - | 5,367 | ||||||||||||||||||
Pre-tax loss attributable to non-controlling interest in ASC | - | 36 | - | 36 | ||||||||||||||||||
Adjusted EBITDA (non-GAAP) | $ | 147,995 | $ | 10,890 | ($28,260 | ) | $ | 130,625 | ||||||||||||||
Table 12 |
||||||||||||||||||||||
Nine Months ended September 30, 2015
(in thousands) |
Machine |
Albany |
Corporate |
Total |
||||||||||||||||||
Net income (GAAP) | $ | 110,969 | ($26,635)* | ($64,535 | ) | $ | 19,799 | |||||||||||||||
Interest expense, net | - | - | 8,049 | 8,049 | ||||||||||||||||||
Income tax expense | - | - | 20,398 | 20,398 | ||||||||||||||||||
Depreciation and amortization | 30,077 | 8,845 | 6,359 | 45,281 | ||||||||||||||||||
EBITDA (non-GAAP) | 141,046 | (17,790 | ) | (29,729 | ) | 93,527 | ||||||||||||||||
Restructuring expenses, net | 13,929 | - | - | 13,929 | ||||||||||||||||||
Foreign currency revaluation losses/(gains) | (4,534 | ) | (17 | ) | 406 | (4,145 | ) | |||||||||||||||
Gain on sale of investment | - | - | (872 | ) | (872 | ) | ||||||||||||||||
Pre-tax income attributable to non-controlling interest in ASC | - | (115 | ) | - | (115 | ) | ||||||||||||||||
Adjusted EBITDA (non-GAAP) | $ | 150,441 | ($17,922 | ) | ($30,195 | ) | $ | 102,324 | ||||||||||||||
*includes $14 million BR725 charge |
||||||||||||||||||||||
Table 13 |
||||||||||||||||||||
Three Months ended September 30, 2016
(in thousands, except per share amounts) |
Pre-tax |
Tax Effect |
After-tax |
Per Share |
||||||||||||||||
Restructuring expenses, net | $ | 326 | $ | 122 | $ | 204 | $ | 0.01 | ||||||||||||
Foreign currency revaluation gains | 222 | 83 | 139 | 0.00 | ||||||||||||||||
Favorable effect of change in income tax rate | - | 425 | 425 | 0.01 | ||||||||||||||||
Net discrete income tax charge | - | 74 | 74 | 0.00 | ||||||||||||||||
Table 14 |
||||||||||||||||||||
Three Months ended September 30, 2015
(in thousands, except per share amounts) |
Pre-tax |
Tax Effect |
After-tax |
Per Share |
||||||||||||||||
Restructuring expenses, net | $ | 3,717 | $ | 1,412 | $ | 2,305 | $ | 0.07 | ||||||||||||
Foreign currency revaluation gains | 1,048 | 398 | 650 | 0.02 | ||||||||||||||||
Favorable effect of change in income tax rate | - | 1,002 | 1,002 | 0.03 | ||||||||||||||||
Net discrete income tax charge | - | 4,914 | 4,914 | 0.15 | ||||||||||||||||
Table 15 |
||||||||||||||||||||
Nine Months ended September 30, 2016
(in thousands, except per share amounts) |
Pre-tax |
Tax Effect |
After-tax |
Per Share |
||||||||||||||||
Restructuring expenses, net | $ | 7,653 | $ | 2,965 | $ | 4,688 | $ | 0.15 | ||||||||||||
Foreign currency revaluation gains | 704 | 256 | 448 | 0.01 | ||||||||||||||||
Acquisition expenses | 5,367 | 1,933 | 3,434 | 0.11 | ||||||||||||||||
Net discrete income tax benefit | - | 932 | 932 | 0.03 | ||||||||||||||||
Table 16 |
||||||||||||||||||||
Nine Months ended September 30, 2015
(in thousands, except per share amounts) |
Pre-tax |
Tax Effect |
After-tax |
Per Share |
||||||||||||||||
Restructuring expenses, net | $ | 13,929 | $ | 5,280 | $ | 8,649 | $ | 0.27 | ||||||||||||
Foreign currency revaluation gains | 4,145 | 1,597 | 2,548 | 0.08 | ||||||||||||||||
Gain on sale of investment | 872 | 331 | 541 | 0.02 | ||||||||||||||||
Net discrete income tax charge | - | 5,113 | 5,113 | 0.16 | ||||||||||||||||
Charge for revision in estimated contract profitability | 14,000 | 5,180 | 8,820 | 0.28 |
The following table contains the calculation of net income per share attributable to the Company, excluding adjustments:
Table 17 |
||||||||||||||||||||||||||||
Per share amounts (Basic) |
Three Months ended September 30, |
Nine Months ended September 30, |
||||||||||||||||||||||||||
2016 |
2015 |
2016 |
2015 |
|||||||||||||||||||||||||
Net income attributable to the Company, reported (GAAP) | $ | 0.41 | $ | 0.30 | $ | 1.15 | $0.62* | |||||||||||||||||||||
Adjustments: | ||||||||||||||||||||||||||||
Restructuring expenses, net | 0.01 | 0.07 | 0.15 | 0.27 | ||||||||||||||||||||||||
Discrete tax adjustments and effect of change in income tax rate | (0.01 | ) | 0.12 | (0.03 | ) | 0.16 | ||||||||||||||||||||||
Foreign currency revaluation (gains)/ losses | - | (0.02 | ) | (0.01 | ) | (0.08 | ) | |||||||||||||||||||||
Acquisition expenses | - | - | 0.11 | - | ||||||||||||||||||||||||
Gain on the sale of investment | - | - | - | (0.02 | ) | |||||||||||||||||||||||
Net income attributable to the Company, excluding adjustments (non-GAAP) | $ | 0.41 | $ | 0.47 | $ | 1.37 | $ | 0.95 | ||||||||||||||||||||
*includes $0.28 per share for BR725 charge |
The following table contains the calculation of net debt:
Table 18 |
||||||||||||||||||||||||||||||
(in thousands) |
September 30, |
June 30, |
March 31, |
December 31, |
September 30, |
|||||||||||||||||||||||||
Notes and loans payable | $ | 343 | $ | 531 | $ | 590 | $ | 587 | $ | 390 | ||||||||||||||||||||
Current maturities of long-term debt | 1,462 | 566 | 16 | 16 | 50,016 | |||||||||||||||||||||||||
Long-term debt | 490,003 | 485,215 | 255,076 | 265,080 | 220,084 | |||||||||||||||||||||||||
Total debt | 491,808 | 486,312 | 255,682 | 265,683 | 270,490 | |||||||||||||||||||||||||
Cash and cash equivalents | 196,170 | 176,025 | 169,615 | 185,113 | 171,780 | |||||||||||||||||||||||||
Net debt | $ | 295,638 | $ | 310,287 | $ | 86,067 | $ | 80,570 | $ | 98,710 | ||||||||||||||||||||
The following table contains the reconciliation of MC 2016 projected Adjusted EBITDA to MC 2016 projected net income:
Table 19 |
||||||||||||||||||||||||||||
Machine Clothing Full Year 2016 Outlook
(in millions) |
Actual, nine |
Results for |
Results for |
Estimated |
||||||||||||||||||||||||
Adjusted EBITDA (non-GAAP) |
$ |
148 | $ | 40 | $ | 50 | $ | 188 - $198 | ||||||||||||||||||||
Less: Restructuring expenses, net | (6 | ) | * | * | (6 | ) | ||||||||||||||||||||||
Less: Foreign currency revaluation losses | (2 | ) | * | * | (2 | ) | ||||||||||||||||||||||
EBITDA (non-GAAP) | $ | 140 | $ | 40 | $ | 50 | $ | 180 - $190 | ||||||||||||||||||||
Less: Depreciation and amortization | (28 | ) | (9 | ) | (9 | ) | (37 | ) | ||||||||||||||||||||
Net income (GAAP) | $ | 112 | $ | 31 | $ | 41 | $ | 143 - $153 |
* Due to the uncertainty of these items, management is currently unable to project restructuring expenses and foreign currency revaluation gains/losses for the remainder of the year.
This press release may contain statements, estimates, or projections that constitute “forward-looking statements” as defined under U.S. federal securities laws. Generally, the words “believe,” “expect,” “intend,” “estimate,” “anticipate,” “project,” “will,” “should,” “look for,” and similar expressions identify forward-looking statements, which generally are not historical in nature. Forward-looking statements are subject to certain risks and uncertainties (including, without limitation, those set forth in the Company’s most recent Annual Report on Form 10-K or Quarterly Report on Form 10-Q) that could cause actual results to differ materially from the Company’s historical experience and our present expectations or projections.
Forward-looking statements in this release or in the webcast include,
without limitation, statements about macroeconomic and paper- industry
trends and conditions during 2016 and in future years; expectations in
2016 and in future periods of sales, EBITDA, Adjusted EBITDA, income,
gross profit, gross margin and other financial items in each of the
Company’s businesses, including the acquired composite aerostructures
business, and for the Company as a whole; the timing and impact of
production and development programs in the Company’s AEC business
segment and the sales growth potential of key AEC programs, as well as
AEC as a whole; the amount and timing of capital expenditures, future
tax rates and cash paid for taxes, depreciation and amortization; future
debt and net debt levels and debt covenant ratios; the timeline for
ASC’s planned facility in
Statements expressing management’s assessments of the growth potential of its businesses, or referring to earlier assessments of such potential, are not intended as forecasts of actual future growth, and should not be relied on as such. While management believes such assessments to have a reasonable basis, such assessments are, by their nature, inherently uncertain. This release and earlier releases set forth a number of assumptions regarding these assessments, including historical results, independent forecasts regarding the markets in which these businesses operate, and the timing and magnitude of orders for our customers’ products.
Historical growth rates are no guarantee of future growth, and such independent forecasts and assumptions could prove materially incorrect, in some cases.
ALBANY INTERNATIONAL CORP. | ||||||||||||||||||||||||
CONSOLIDATED STATEMENTS OF INCOME | ||||||||||||||||||||||||
(in thousands, except per share data) | ||||||||||||||||||||||||
(unaudited) | ||||||||||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||
2016 | 2015 | 2016 | 2015 | |||||||||||||||||||||
Net sales |
$ |
191,272 |
$ |
178,789 |
$ |
566,793 |
$ |
532,402 |
||||||||||||||||
Cost of goods sold | 118,852 | 103,045 | 343,557 | 325,382 | ||||||||||||||||||||
Gross profit | 72,420 | 75,744 | 223,236 | 207,020 | ||||||||||||||||||||
Selling, general, and administrative expenses | 38,042 | 35,509 | 120,997 | 110,674 | ||||||||||||||||||||
Technical, product engineering, and research expenses | 9,232 | 10,675 | 29,640 | 33,387 | ||||||||||||||||||||
Restructuring expenses, net | 326 | 3,717 | 7,653 | 13,929 | ||||||||||||||||||||
Operating income | 24,820 | 25,843 | 64,946 | 49,030 | ||||||||||||||||||||
Interest expense, net | 3,681 | 2,671 | 9,610 | 8,049 | ||||||||||||||||||||
Other (income)/expense, net | 242 | 1,249 | (2,103 | ) | 784 | |||||||||||||||||||
Income before income taxes | 20,897 | 21,923 | 57,439 | 40,197 | ||||||||||||||||||||
Income tax expense | 7,488 | 12,243 | 20,613 | 20,398 | ||||||||||||||||||||
Net income | 13,409 | 9,680 | 36,826 | 19,799 | ||||||||||||||||||||
Net (loss)/income attributable to the noncontrolling interest | 340 | 22 | (111 | ) | 100 | |||||||||||||||||||
Net income attributable to the Company | $ | 13,069 | $ | 9,658 | $ | 36,937 | $ | 19,699 | ||||||||||||||||
Earnings per share attributable to Company shareholders - Basic | $ | 0.41 | $ | 0.30 | $ | 1.15 | $ | 0.62 | ||||||||||||||||
Earnings per share attributable to Company shareholders - Diluted | $ | 0.41 | $ | 0.30 | $ | 1.15 | $ | 0.62 | ||||||||||||||||
Shares of the Company used in computing earnings per share: | ||||||||||||||||||||||||
Basic | 32,104 | 32,012 | 32,079 | 31,965 | ||||||||||||||||||||
Diluted | 32,141 | 32,055 | 32,118 | 32,028 | ||||||||||||||||||||
Dividends per share, Class A and Class B | $ | 0.17 | $ | 0.17 | $ | 0.51 | $ | 0.50 | ||||||||||||||||
ALBANY INTERNATIONAL CORP. | ||||||||||||||
CONSOLIDATED BALANCE SHEETS | ||||||||||||||
(in thousands, except share data) | ||||||||||||||
(unaudited) | ||||||||||||||
September 30, | December 31, | |||||||||||||
2016 | 2015 | |||||||||||||
ASSETS | ||||||||||||||
Cash and cash equivalents | $ | 196,170 | $ | 185,113 | ||||||||||
Accounts receivable, net | 170,739 | 146,383 | ||||||||||||
Inventories | 138,688 | 106,406 | ||||||||||||
Income taxes prepaid and receivable | 1,303 | 2,927 | ||||||||||||
Asset held for sale | 5,179 | 4,988 | ||||||||||||
Prepaid expenses and other current assets | 10,078 | 6,243 | ||||||||||||
Total current assets | 522,157 | 452,060 | ||||||||||||
Property, plant and equipment, net | 441,608 | 357,470 | ||||||||||||
Intangibles, net | 57,044 | 154 | ||||||||||||
Goodwill | 134,724 | 66,373 | ||||||||||||
Income taxes receivable and deferred | 78,689 | 108,945 | ||||||||||||
Other assets | 31,400 | 24,560 | ||||||||||||
Total assets | $ | 1,265,622 | $ | 1,009,562 | ||||||||||
LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||
Notes and loans payable | $ | 343 | $ | 587 | ||||||||||
Accounts payable | 36,653 | 26,753 | ||||||||||||
Accrued liabilities | 96,483 | 91,785 | ||||||||||||
Current maturities of long-term debt | 1,462 | 16 | ||||||||||||
Income taxes payable | 12,176 | 7,090 | ||||||||||||
Total current liabilities | 147,117 | 126,231 | ||||||||||||
Long-term debt | 490,003 | 265,080 | ||||||||||||
Other noncurrent liabilities | 98,123 | 101,544 | ||||||||||||
Deferred taxes and other liabilities | 5,256 | 14,154 | ||||||||||||
Total liabilities | 740,499 | 507,009 | ||||||||||||
SHAREHOLDERS' EQUITY | ||||||||||||||
Preferred stock, par value $5.00 per share; | ||||||||||||||
authorized 2,000,000 shares; none issued | - | - | ||||||||||||
Class A Common Stock, par value $.001 per share; | ||||||||||||||
authorized 100,000,000 shares; issued 37,315,016 | ||||||||||||||
in 2016 and 37,238,913 in 2015 | 37 | 37 | ||||||||||||
Class B Common Stock, par value $.001 per share; | ||||||||||||||
authorized 25,000,000 shares; issued and | ||||||||||||||
outstanding 3,235,048 in 2016 and 2015 | 3 | 3 | ||||||||||||
Additional paid in capital | 425,315 | 423,108 | ||||||||||||
Retained earnings | 512,517 | 491,950 | ||||||||||||
Accumulated items of other comprehensive income: | ||||||||||||||
Translation adjustments | (106,439 | ) | (108,655 | ) | ||||||||||
Pension and postretirement liability adjustments | (48,023 | ) | (48,725 | ) | ||||||||||
Derivative valuation adjustment | (4,719 | ) | (1,464 | ) | ||||||||||
Treasury stock (Class A), at cost 8,443,902 shares | ||||||||||||||
in 2016 and 8,455,293 shares in 2015 | (257,146 | ) | (257,391 | ) | ||||||||||
Total Company shareholders' equity | 521,545 | 498,863 | ||||||||||||
Noncontrolling interest | 3,578 | 3,690 | ||||||||||||
Total equity | 525,123 | 502,553 | ||||||||||||
Total liabilities and shareholders' equity | $ | 1,265,622 | $ | 1,009,562 | ||||||||||
ALBANY INTERNATIONAL CORP. | |||||||||||||||||||||||||||||
CONSOLIDATED STATEMENTS OF CASH FLOW | |||||||||||||||||||||||||||||
(in thousands) | |||||||||||||||||||||||||||||
(unaudited) | |||||||||||||||||||||||||||||
Three Months Ended |
Nine Months Ended |
||||||||||||||||||||||||||||
2016 | 2015 | 2016 | 2015 | ||||||||||||||||||||||||||
OPERATING ACTIVITIES | |||||||||||||||||||||||||||||
Net income | $ | 13,409 | $ | 9,680 | $ | 36,826 | $ | 19,799 | |||||||||||||||||||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||||||||||||||||||||
Depreciation | 16,470 | 12,953 | 44,736 | 39,850 | |||||||||||||||||||||||||
Amortization | 1,975 | 1,790 | 6,488 | 5,431 | |||||||||||||||||||||||||
Change in other noncurrent liabilities | (275 | ) | (188 | ) | (6,282 | ) | (1,732 | ) | |||||||||||||||||||||
Change in deferred taxes and other liabilities | (1,712 | ) | 7,322 | (640 | ) | 2,669 | |||||||||||||||||||||||
Provision for write-off of property, plant and equipment | 333 | (156 | ) | 1,409 | 259 | ||||||||||||||||||||||||
Gain on disposition of assets | - | - | - | (1,056 | ) | ||||||||||||||||||||||||
Excess tax benefit of options exercised | (11 | ) | - | (116 | ) | (603 | ) | ||||||||||||||||||||||
Compensation and benefits paid or payable in Class A Common Stock | 350 | 290 | 1,882 | 1,285 | |||||||||||||||||||||||||
Fair value adjustment on available-for-sale assets | - | 3,225 | - | 3,225 | |||||||||||||||||||||||||
Changes in operating assets and liabilities that provide/(use) cash, net of impact of business acquisition: | |||||||||||||||||||||||||||||
Accounts receivable | 4,794 | 5,100 | (6,492 | ) | (4,387 | ) | |||||||||||||||||||||||
Inventories | (5,511 | ) | (3,626 | ) | (12,886 | ) | (10,757 | ) | |||||||||||||||||||||
Prepaid expenses and other current assets | (481 | ) | 133 | (3,302 | ) | (857 | ) | ||||||||||||||||||||||
Income taxes prepaid and receivable | (100 | ) | (518 | ) | 1,737 | (592 | ) | ||||||||||||||||||||||
Accounts payable | (4,443 | ) | (3,126 | ) | (1,544 | ) | (4,467 | ) | |||||||||||||||||||||
Accrued liabilities | 4,418 | 3,381 | (3,736 | ) | 861 | ||||||||||||||||||||||||
Income taxes payable | 4,932 | 3,910 | 3,999 | 3,987 | |||||||||||||||||||||||||
Other, net | (4,974 | ) | 1,723 | (10,252 | ) | 6,330 | |||||||||||||||||||||||
Net cash provided by operating activities | 29,174 | 41,893 | 51,827 | 59,245 | |||||||||||||||||||||||||
INVESTING ACTIVITIES | |||||||||||||||||||||||||||||
Purchase of business, net of cash acquired | - | - | (187,000 | ) | - | ||||||||||||||||||||||||
Purchases of property, plant and equipment | (21,924 | ) | (9,023 | ) | (50,029 | ) | (39,689 | ) | |||||||||||||||||||||
Purchased software | (591 | ) | (252 | ) | (1,262 | ) | (589 | ) | |||||||||||||||||||||
Proceeds from sale or involuntary conversion of assets | 4,686 | - | 6,422 | 2,797 | |||||||||||||||||||||||||
Net cash used in investing activities | (17,829 | ) | (9,275 | ) | (231,869 | ) | (37,481 | ) | |||||||||||||||||||||
FINANCING ACTIVITIES | |||||||||||||||||||||||||||||
Proceeds from borrowings | 13,265 | 5,198 | 232,795 | 44,818 | |||||||||||||||||||||||||
Principal payments on debt | (871 | ) | (37,354 | ) | (23,695 | ) | (47,100 | ) | |||||||||||||||||||||
Debt acquisition costs | - | (41 | ) | (1,771 | ) | (1,671 | ) | ||||||||||||||||||||||
Swap termination payment | - | - | (5,175 | ) | - | ||||||||||||||||||||||||
Proceeds from options exercised | 64 | 75 | 454 | 1,799 | |||||||||||||||||||||||||
Excess tax benefit of options exercised | 11 | - | 116 | 603 | |||||||||||||||||||||||||
Dividends paid | (5,457 | ) | (5,441 | ) | (16,354 | ) | (15,646 | ) | |||||||||||||||||||||
Net cash provided by/(used in) financing activities | 7,012 | (37,563 | ) | 186,370 | (17,197 | ) | |||||||||||||||||||||||
Effect of exchange rate changes on cash and cash equivalents | 1,788 | (5,749 | ) | 4,729 | (12,589 | ) | |||||||||||||||||||||||
Increase/(decrease) in cash and cash equivalents | 20,145 | (10,694 | ) | 11,057 | (8,022 | ) | |||||||||||||||||||||||
Cash and cash equivalents at beginning of period | 176,025 | 182,474 | 185,113 | 179,802 | |||||||||||||||||||||||||
Cash and cash equivalents at end of period | $ | 196,170 | $ | 171,780 | $ | 196,170 | $ | 171,780 | |||||||||||||||||||||
View source version on businesswire.com: http://www.businesswire.com/news/home/20161031006132/en/
Source:
Albany International Corp.
Investors
John Cozzolino,
518-445-2281
john.cozzolino@albint.com
or
Media
Heather
Kralik, 801-505-7001
heather.kralik@albint.com